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Abstract
Neil Lunt and Russel Mannion provide an overview of the current state of the medical tourism literature and propose 
areas for future research in health policy and management. The authors also identify the main unanswered questions 
in this field ranging from the real size of the medical tourism market to the particular health profiles of transnational 
patients. In addition, they highlight unexplored areas of research from health economics, ethics, policy and management 
perspectives. To this very insightful editorial I would add the international trade perspective. While globalization 
has permeated labor and capital, services such as healthcare are still highly regulated by governments, constrained 
to regional or national borders and protected by organized interests. Heterogeneity of healthcare regulations and 
lack of cross-country reciprocity agreements act as barriers to the development of more widespread and dynamic 
medical tourism markets. To picture these barriers to transnational health services I use evidence from North America, 
identifying different “pull and push factors” for medical tourist in this region, discussing how economic integration and 
healthcare reform might shift the incentives to utilize healthcare abroad. 
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Introduction
As Neil Lunt and Russel Mannion point out in their 
editorial, medical tourism promotion is prone to “provider 
exaggeration, and industry ‘grand standing’, [making it 
increasingly] difficult to distinguish rhetoric from reality” 
(p.156) (1). Scholars who have attempted to investigate the 
size, characteristics, and prospects of different medical 
tourism markets often times encounter data limitations and 
difficulties agreeing on adequate conceptual frameworks and 
disciplinary boundaries. In spite of it, Lunt and Mannion 
highlight some of the main contributions to this literature that 
have made a conscious effort to investigate medical tourism 
from a scientific perspective, differentiating it from the 
overboard marketing that characterizes this field. The authors 
also provide an excellent overview of the main unanswered 
questions in this field ranging from the real size of the medical 
tourism market to the specific health profiles of international 
patients. One of the main contributions of this editorial is the 
overview of specific areas for future research by health policy 
and management sub disciplines, such as health economics, 
health policy ethics, politics of health, health management, 
and health policy. 
Globalization and healthcare
From my perspective, two of the main areas for future research 
in medical tourism are: i) the characterization of market failures 
in medical tourism markets; and ii) how specific transnational 
healthcare markets could evolve within existing economic 
association agreements. Economic liberalization since the 
1970s has eliminated trade barriers in manufacturing and the 
financial sector, transforming how labor and capital—two key 
elements of modern capitalist societies—are used in national 
economies. Today cars, phones, appliances, and several other 
manufactured products are assembles in production lines 
that cover different continents and a multiplicity of countries. 
Capital flows also move with relative ease across national 
borders speeding up international economic integration. 
Governments have promoted globalization by opening 
borders, harmonizing regulations, and overcoming resistance 
from organized interests who benefited in the past from 
protectionist measures. By contrast, in most service sectors, 
such as education or healthcare, economic liberalization 
and internationalization has been less widespread. Services 
in most countries remain highly regulated by governments, 
constrained to regional or national borders and protected by 
organized interests.
Healthcare is still a local industry in most countries. Regional 
and national governments remain as the main payers in 
many countries and in some cases the main provider of 
health services and employer of the healthcare workforce. 
Incompatible cross-national healthcare regulations and 
organized interests have often mobilized to erect protectionist 
measures to prevent rule homogenization or reciprocity 
agreements that could facilitate healthcare quality regulations 
and patient management across countries. Governments have 
been passive at facing this opposition. Globalization, however, 
has been slowly permeating the healthcare ‘production line’, 
from growing healthcare outsourcing to increasing mobility 
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of professionals and patients. We are currently witnessing 
the first stages of healthcare internationalization triggered by 
cost differentials across countries and increasing patient and 
provider mobility due to lower transportation costs and better 
information technologies. 
Health systems around the world have different financing, 
organization, and delivery characteristics. Specific features of 
these health systems such as cost sharing, rationing, provider 
choice, can act as incentives for patients to travel abroad in 
search of better alternatives. For instance, the European 
and U.S.-Mexico transnational healthcare markets are very 
different in terms of motivations to travel aboard and patient 
demographics. In the U.S.-Mexico transnational market the 
main incentives for medical tourist form the U.S. to travel 
south of the border are the high healthcare costs, access to 
care barriers for minority and low-income populations in 
the U.S., and cultural familiarity with the Mexican health 
system in the case of the Mexican diaspora in the U.S. (2). By 
contrast, in the European Union the incentives of patients to 
seek healthcare abroad are often times explained by rationing 
of specific treatments and access to more affordable elective 
procedures abroad (3). These two cases show that in addition 
to cost differentials, other considerations such as access to 
care, service availability and type of procedures are key issues 
to consider in medical tourism conceptual frameworks.  
One of the main questions that medical tourism scholars 
would start to face in the upcoming years is how transnational 
healthcare markets develop and follow similar economic 
liberalization trajectories as economic integration in other 
economic sectors, such as manufacturing or finances. Health 
policy and management scholars could analyze this trajectory 
from an international trade perspective, investigating how 
healthcare liberalization evolves within current economic 
association agreements such as the European Union, 
the North American Free Trade Agreement (NAFTA), 
MERCOSUR or ASEAN. As Lunt and Mannion mention in 
their commentary, a variety of “push and pull factors” explain 
increasing international patient mobility. Centering this 
framework in specific economic zones could help identify 
specific policies and regulations that address existing market 
failures in medical tourism market and create new institutions 
and organizations to more effectively manage transnational 
patient mobility.  
The North American experience
In the specific case of NAFTA, Canada, the U.S. and Mexico 
have substantially increased their economic interactions 
in the last two decades. Since NAFTA was signed in 1993 
international trade between the U.S. and Mexico has increased 
six-fold and almost 5 million Mexicans have migrated to 
the U.S. attracted by new economic opportunities. “Push” 
factors that incentivize medical tourism in the U.S.-Mexico 
region are access to care barriers for Mexicans in the U.S., 
an ageing population that each year increases the number 
of U.S. retirees moving south to Mexico in search of better 
weather and a more affordable lifestyle, and significant cost 
differentials for most health services in the two countries (4). 
Likewise, “pull” factors that promote transnational patient 
mobility in this region are geographic proximity, declining 
transportation costs, cultural familiarity with the Mexican 
healthcare system among 30 million Mexicans who live in the 
U.S. and an active policy by private hospitals in Mexico to seek 
international certification in order to make themselves more 
attractive to medical tourists. In spite of these factors that 
incentivize transnational healthcare utilization in the region, 
heterogeneity of  healthcare regulations across Canada, the U.S. 
and Mexico; and lack of cross-country reciprocity agreements 
on quality of care supervision and patient management act as 
barriers to the development of more widespread and dynamic 
medical tourism markets in North America. 
Under NAFTA, Canada, the U.S. and Mexico have established 
new healthcare collaborations. For instance, Canada provides 
health coverage for seasonal farmworkers from Mexico. 
The U.S. state of California has regulations that allow local 
health insurers to offer health coverage in Mexico for U.S. 
workers (5). In spite of these timid efforts to increase cross-
border collaborations, protectionist measures have prevented 
further integration of healthcare markets. For instance, the 
U.S. state of Texas rejected a law proposal that resembled 
California’s health insurance cross-border legislation due 
to the lobbying from local healthcare providers who feared 
increased competition from lower cost providers in Mexico 
(6). Canada’s Medicare once reimbursed members who used 
healthcare in the U.S. but stopped doing so as a cost control 
measure. Similarly, the legal framework that introduced 
private managed care organizations in Mexico as part of 
NAFTA was opposed by local unions and healthcare providers 
(7). The resulting legislation diluted all incentives for the 
expansion of international private health insurers in Mexico, 
slowing down the integration of North American healthcare 
organizations that could have offered better coverage to 
increasingly mobile populations. 
These examples suggest that in spite of trade liberalization 
in North America, market failures in healthcare delivery 
for transnational populations are likely to remain in place 
for some time. Governments’ attention currently focuses 
on domestic health policy. Both, Mexico and the U.S. have 
recently implemented ambitious healthcare reforms that will 
expand health insurance coverage to millions of currently 
uninsured individuals. It is still unclear whether these reforms 
would be effective at reducing the demand for healthcare 
abroad or if they would just shift the type of services that 
medical tourists would seek abroad. As suggested by Lunt 
and Mannion, health policy and management scholars would 
need to identify new “push and pull factors” that will drive 
medical tourists abroad. In the upcoming years, medical 
tourism scholars could analyze how health policy changes 
shifted incentives to utilize healthcare abroad. In addition, 
they could analyze how increasing economic integration 
put more pressure on governments to coordinate across 
nationalboarders to ensure quality of care for medical tourists 
and a better way of financing transnational health services.  
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